Bifidobacterium vaginale G

Information

Microbe Identification

Bifidobacterium vaginale G

Microbe id: PMDBM2008261
Level: species
NCBI Taxonomy ID: n.a.
Taxonomy Species: Bifidobacterium vaginale [n.a.]
Taxonomy Genus: Bifidobacterium [1678]
Taxonomy Family: Bifidobacteriaceae [31953]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Bifidobacterium vaginale G

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Bifidobacterium vaginale G


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Bifidobacterium vaginale G distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Bifidobacterium vaginale G in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Bifidobacterium vaginale G

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Hemangioma, Cavernous PRJNA629755🔗-4.23641985499353mNGS
Diabetes Mellitus, Type 2 PRJNA646010🔗4.0524397996068416S
Diabetes Mellitus, Type 2 PRJNA588353🔗4.6938128958833816S
Diarrhea PRJEB14038🔗-3.57256388617739mNGS
Dwarfism PRJNA808649🔗4.88764507834379mNGS
Colorectal Neoplasms PRJDB11845🔗-4.4912391046111816S
Colorectal Neoplasms PRJNA936589🔗-4.45579288927694mNGS
Colorectal Neoplasms PRJNA1167935🔗-4.13366004062505mNGS
Colorectal Neoplasms PRJNA1050885🔗4.8446369117255mNGS
Acne Vulgaris PRJNA449243🔗-4.3076836387705316S
Diabetes Mellitus, Type 1 PRJNA871997🔗-4.736934354120516S
Hepatitis, Autoimmune PRJNA556801🔗3.5976758873850616S
Parkinson Disease PRJNA588035🔗3.65832657308594mNGS
Parkinson Disease PRJEB53401🔗3.93283742124032mNGS
Parkinson Disease PRJNA742875🔗4.4513192550877116S
Parkinson Disease PRJEB59350🔗4.4558022764857mNGS
Colitis, Ulcerative PRJNA820056🔗-3.7442166788313316S
Colitis, Ulcerative PRJNA804422🔗5.1824409175358416S
Campylobacter Infections PRJNA660443🔗-3.81949984188333mNGS
Spinal Cord Injuries PRJNA861246🔗-4.134648332694416S
Spinal Cord Injuries PRJNA669472🔗4.9477197360994116S
Osteoporosis, Postmenopausal PRJNA946183🔗-4.29227377508065mNGS
Carcinoma, Renal Cell PRJNA842560🔗4.103488007637916S
Colorectal Neoplasms, Hereditary Nonpolyposis PRJNA939026🔗-4.91629813895066mNGS
Esophageal Neoplasms PRJNA698746🔗4.3820773522161716S
Caliciviridae Infections PRJNA788674🔗4.9876456631252816S
Hepatolenticular Degeneration PRJNA1038771🔗5.0085603654298816S
Psychotic Disorders PRJNA1044118🔗5.08018082419829mNGS
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-4.0441661207280716S
Tic Disorders PRJNA780788🔗5.3917161175188416S
Crohn Disease PRJNA1156939🔗-4.6567420646257116S
Crohn Disease PRJEB42155🔗-4.25489239255818mNGS
Crohn Disease PRJNA820056🔗-3.8900808669379916S
Crohn Disease PRJNA793776🔗3.93533168205436mNGS
Psoriasis PRJNA938297🔗4.80159020667379mNGS
Schistosomiasis haematobia PRJNA526732🔗3.0472290207337416S
Multiple System Atrophy PRJNA532538🔗-4.70574194093558mNGS
Arthritis, Rheumatoid PRJNA896336🔗-3.992766537302mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-3.2078051890055mNGS
Cholangiocarcinoma PRJNA932948🔗-4.41641732556023mNGS
Anorexia Nervosa PRJEB11199🔗4.2428526593289716S
Hepatitis C PRJNA328966🔗-4.5908578867596916S
Hepatitis C PRJNA1070593🔗-4.133886178756816S
Neuroblastoma PRJNA716780🔗-4.90762521949692mNGS
Hematologic Neoplasms PRJNA777832🔗-4.4846787305339416S
Digestive System Diseases PRJNA438404🔗-4.5111405901205116S
Clostridium Infections PRJNA648321🔗-5.08720612997041mNGS
Kidney Calculi PRJNA742740🔗-3.9724605306968mNGS
Alzheimer Disease PRJEB51982🔗-4.4056254092215616S
Atrial Fibrillation PRJNA728204🔗-4.8528371954568316S
Lung Neoplasms PRJNA507734🔗-4.5078268458668116S
Obesity PRJNA794317🔗-5.2971090840107116S
Enterocolitis, Necrotizing PRJNA889687🔗-4.9569038419156316S
Autism Spectrum Disorder PRJEB42687🔗4.0961108672039316S
Autism Spectrum Disorder PRJEB45948🔗4.6481607972406916S
Inflammatory Bowel Diseases PRJNA511372🔗5.3104111350241mNGS
Hand, Foot and Mouth Disease PRJNA1017976🔗-5.2423663485148116S
Renal Insufficiency, Chronic PRJNA659589🔗4.6950689484491816S
Malaria PRJNA642859🔗-4.6231662517185816S
Fibromyalgia PRJEB80379🔗-4.56998592066672mNGS
Amebiasis PRJNA608066🔗4.1895106398895316S
COVID-19 PRJNA1031953🔗-5.4589589090001516S
COVID-19 PRJDB13214🔗-4.84355481762877mNGS
COVID-19 PRJNA689961🔗-4.80461833374374mNGS
COVID-19 PRJNA678695🔗-3.0006990974474216S
Sepsis PRJNA641414🔗4.0899260220469116S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Bifidobacterium vaginale G



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Bifidobacterium vaginale G



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Bifidobacterium vaginale G

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Bifidobacterium vaginale G


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Bifidobacterium vaginale G



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Bifidobacterium vaginale G

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Bifidobacterium vaginale G

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Bifidobacterium vaginale G

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Bifidobacterium vaginale G



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Bifidobacterium vaginale G


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Bifidobacterium vaginale G


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?